Alvotech (ALVO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements [Yahoo! Finance]
Alvotech (ALVO)
Company Research
Source: Yahoo! Finance
Product Revenue: $128 million for the first nine months, a 330% increase from the prior year. Milestone Revenue: $211 million for the first nine months, compared to $8 million in the prior year. Third Quarter Revenue: $103 million, up from $18 million in the prior year. Third Quarter Product Revenue: $62 million, the highest recorded quarter by Alvotech, a 16% increase from Q2. Product Margin: 37% in Q3, up from 17% in Q2. Operating Profit: $56 million for the first nine months, compared to negative $278 million in the same period of 2023. Adjusted EBITDA: $87 million for the first nine months, compared to negative $226 million in the prior year. Cash on Hand: $118 million as of September 30, 2024. Borrowings: $1.28 billion as of September 30, 2024. Shares Outstanding: 301.7 million, including unvested earnout shares. Revenue Guidance: $400 million to $500 million for 2024. Cash Interest Payments Forecast: $45 million to $50 million for 2024. Warning! GuruFocu
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech's Position In The Coming Biosimilar Gold Rush [Seeking Alpha]Seeking Alpha
- Alvotech (ALVO) Q3 Earnings and Revenues Beat Estimates [Yahoo! Finance]Yahoo! Finance
- Alvotech Reports Financial Results for the First Nine Months of 2024 [Yahoo! Finance]Yahoo! Finance
- Alvotech Reports Financial Results for the First Nine Months of 2024GlobeNewswire
- Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024GlobeNewswire
ALVO
Earnings
- 5/21/24 - Miss
ALVO
Sec Filings
- 11/13/24 - Form 6-K
- 11/6/24 - Form SC
- 11/4/24 - Form 6-K
- ALVO's page on the SEC website